These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 9001293

  • 1. Two-step tuberculin skin testing in HIV-infected persons in Uganda.
    Hecker MT, Johnson JL, Whalen CC, Nyole S, Mugerwa RD, Ellner JJ.
    Am J Respir Crit Care Med; 1997 Jan; 155(1):81-6. PubMed ID: 9001293
    [Abstract] [Full Text] [Related]

  • 2. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL, Nyole S, Okwera A, Whalen CC, Nsubuga P, Pekovic V, Huebner R, Wallis RS, Mugyenyi PN, Mugerwa RD, Ellner JJ.
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1790-6. PubMed ID: 9847269
    [Abstract] [Full Text] [Related]

  • 3. Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand.
    Yanai H, Uthaivoravit W, Mastro TD, Limpakarnjanarat K, Sawanpanyalert P, Morrow RH, Nieburg P.
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):427-34. PubMed ID: 9441097
    [Abstract] [Full Text] [Related]

  • 4. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1997 Sep 05; 46(RR-15):1-10. PubMed ID: 9332982
    [Abstract] [Full Text] [Related]

  • 5. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
    Aisu T, Raviglione MC, van Praag E, Eriki P, Narain JP, Barugahare L, Tembo G, McFarland D, Engwau FA.
    AIDS; 1995 Mar 05; 9(3):267-73. PubMed ID: 7755915
    [Abstract] [Full Text] [Related]

  • 6. Correlation between CD4+ lymphocyte counts, concurrent antigen skin test and tuberculin skin test reactivity in human immunodeficiency virus type 1-infected and -uninfected children with tuberculosis.
    Madhi SA, Gray GE, Huebner RE, Sherman G, McKinnon D, Pettifor JM.
    Pediatr Infect Dis J; 1999 Sep 05; 18(9):800-5. PubMed ID: 10493341
    [Abstract] [Full Text] [Related]

  • 7. Delayed-type hypersensitivity anergy in human immunodeficiency virus-infected persons screened for infection with Mycobacterium tuberculosis.
    Huebner RE, Schein MF, Hall CA, Barnes SA.
    Clin Infect Dis; 1994 Jul 05; 19(1):26-32. PubMed ID: 7948554
    [Abstract] [Full Text] [Related]

  • 8. Lack of direct correlation between CD4 T-lymphocyte counts and induration sizes of the tuberculin skin test in human immunodeficiency virus type 1 seropositive patients.
    Diagbouga S, Fumoux F, Ledru E, Sanou PT, Barro D, Marchal G.
    Int J Tuberc Lung Dis; 1998 Apr 05; 2(4):317-23. PubMed ID: 9559403
    [Abstract] [Full Text] [Related]

  • 9. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country.
    Stephan C, Wolf T, Goetsch U, Bellinger O, Nisius G, Oremek G, Rakus Z, Gottschalk R, Stark S, Brodt HR, Staszewski S.
    AIDS; 2008 Nov 30; 22(18):2471-9. PubMed ID: 19005270
    [Abstract] [Full Text] [Related]

  • 10. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research.
    Klein RS, Flanigan T, Schuman P, Smith D, Vlahov D.
    Int J Tuberc Lung Dis; 1999 Aug 30; 3(8):681-8. PubMed ID: 10460100
    [Abstract] [Full Text] [Related]

  • 11. Two-stage tuberculin skin testing in an HIV-infected population: a preliminary report.
    Goldstein S, Perlman DC, Salomon N.
    Mt Sinai J Med; 1994 Sep 30; 61(4):337-40. PubMed ID: 7969227
    [Abstract] [Full Text] [Related]

  • 12. Mantoux reaction in patients with HIV-related pulmonary tuberculosis in Maiduguri, Nigeria.
    Yusuph H, Garbati MA, Gashau W.
    Afr J Med Med Sci; 2005 Jun 30; 34(2):125-8. PubMed ID: 16749335
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tuberculin skin testing in intravenous drug users: differences between HIV-seropositive and HIV-seronegative subjects.
    Portu JJ, Aldamiz-Etxebarria M, Agud JM, Arévalo JM, Almaraz MJ, Ayensa C.
    Addict Biol; 2002 Apr 30; 7(2):235-41. PubMed ID: 12006219
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff.
    Janis EM, Allen DW, Glesby MJ, Carey LA, Mundy LM, Gopalan R, Chaisson RE.
    Am J Med; 1996 Feb 30; 100(2):186-92. PubMed ID: 8629653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.